> 0 1 0 1 O
4 2 3 2 3 B-lower_bound
weeks 4 9 4 9 I-lower_bound
since 10 15 10 15 O
major 16 21 16 21 B-treatment
surgery 22 29 22 29 I-treatment

Absolute 0 8 30 38 B-clinical_variable
neutrophil 9 19 39 49 I-clinical_variable
count 20 25 50 55 I-clinical_variable
> 26 27 56 57 O
= 27 28 57 58 O
1,500 29 34 59 64 B-lower_bound
/ 34 35 64 65 I-lower_bound
uL 35 37 65 67 I-lower_bound

Aspartate 0 9 68 77 B-clinical_variable
aminotransferase 10 26 78 94 I-clinical_variable
( 27 28 95 96 I-clinical_variable
AST 28 31 96 99 I-clinical_variable
) 31 32 99 100 I-clinical_variable
and 33 36 101 104 O
alanine 37 44 105 112 B-clinical_variable
aminotransferase 45 61 113 129 I-clinical_variable
( 62 63 130 131 I-clinical_variable
ALT 63 66 131 134 I-clinical_variable
) 66 67 134 135 I-clinical_variable
= 68 69 136 137 O
< 69 70 137 138 O
3 71 72 139 140 B-upper_bound
X 73 74 141 142 I-upper_bound
ULN 75 78 143 146 I-upper_bound

Bilirubin 0 9 147 156 B-clinical_variable
= 10 11 157 158 O
< 11 12 158 159 O
1.5 13 16 160 163 B-upper_bound
X 17 18 164 165 I-upper_bound
ULN 19 22 166 169 I-upper_bound

Creatinine 0 10 170 180 B-clinical_variable
< 11 12 181 182 O
1.5 13 16 183 186 B-upper_bound
X 17 18 187 188 I-upper_bound
upper 19 24 189 194 I-upper_bound
limit 25 30 195 200 I-upper_bound
of 31 33 201 203 I-upper_bound
normal 34 40 204 210 I-upper_bound
( 41 42 211 212 I-upper_bound
ULN 42 45 212 215 I-upper_bound
) 45 46 215 216 I-upper_bound

Eastern 0 7 217 224 B-clinical_variable
Cooperative 8 19 225 236 I-clinical_variable
Oncology 20 28 237 245 I-clinical_variable
Group 29 34 246 251 I-clinical_variable
( 35 36 252 253 I-clinical_variable
ECOG 36 40 253 257 I-clinical_variable
) 40 41 257 258 I-clinical_variable
performance 42 53 259 270 I-clinical_variable
status 54 60 271 277 I-clinical_variable
: 60 61 277 278 O
0 62 63 279 280 B-lower_bound
- 63 64 280 281 O
1 64 65 281 282 B-upper_bound

Estimated 0 9 283 292 O
glomerular 10 20 293 303 B-clinical_variable
filtration 21 31 304 314 I-clinical_variable
rate 32 36 315 319 I-clinical_variable
( 37 38 320 321 I-clinical_variable
GFR 38 41 321 324 I-clinical_variable
) 41 42 324 325 I-clinical_variable
> 43 44 326 327 O
30 45 47 328 330 B-lower_bound
ml 48 50 331 333 I-lower_bound
/ 50 51 333 334 I-lower_bound
min 51 54 334 337 I-lower_bound

Hemoglobin 0 10 338 348 B-clinical_variable
> 11 12 349 350 O
= 12 13 350 351 O
9 14 15 352 353 B-lower_bound
g 16 17 354 355 I-lower_bound
/ 17 18 355 356 I-lower_bound
dL 18 20 356 358 I-lower_bound

Negative 0 8 359 367 B-pregnancy
pregnancy 9 18 368 377 I-pregnancy
test 19 23 378 382 O
in 24 26 383 385 O
women 27 32 386 391 B-gender
of 33 35 392 394 O
childbearing 36 48 395 407 O
age 49 52 408 411 B-age

No 0 2 412 414 O
> 3 4 415 416 O
= 4 5 416 417 O
grade 6 11 418 423 B-lower_bound
2 12 13 424 425 I-lower_bound
sensory 14 21 426 433 O
peripheral 22 32 434 444 B-chronic_disease
neuropathy 33 43 445 455 I-chronic_disease

No 0 2 456 458 O
evidence 3 11 459 467 O
of 12 14 468 470 O
extrapancreatic 15 30 471 486 B-chronic_disease
disease 31 38 487 494 I-chronic_disease
by 39 41 495 497 O
cross 42 47 498 503 B-treatment
sectional 48 57 504 513 I-treatment
imaging 58 65 514 521 I-treatment
, 65 66 521 522 O
PET 67 70 523 526 B-treatment
scan 71 75 527 531 I-treatment
, 75 76 531 532 O
or 77 79 533 535 O
laparoscopy 80 91 536 547 B-treatment
, 91 92 547 548 O
including 93 102 549 558 O
nodal 103 108 559 564 O
involvement 109 120 565 576 O
beyond 121 127 577 583 O
the 128 131 584 587 O
peripancreatic 132 146 588 602 O
tissues 147 154 603 610 O
and/or 155 161 611 617 O
distant 162 169 618 625 O
metastases 170 180 626 636 B-cancer

No 0 2 637 639 O
evidence 3 11 640 648 O
of 12 14 649 651 O
tumor 15 20 652 657 B-cancer
extension 21 30 658 667 O
to 31 33 668 670 O
superior 34 42 671 679 O
mesenteric 43 53 680 690 O
artery 54 60 691 697 O
, 60 61 697 698 O
hepatic 62 69 699 706 O
artery 70 76 707 713 O
, 76 77 713 714 O
celiac 78 84 715 721 O
axis 85 89 722 726 O
, 89 90 726 727 O
aorta 91 96 728 733 O
, 96 97 733 734 O
or 98 100 735 737 O
inferior 101 109 738 746 O
vena 110 114 747 751 O
cava 115 119 752 756 O
, 119 120 756 757 O
and 121 124 758 761 O
no 125 127 762 764 O
evidence 128 136 765 773 O
of 137 139 774 776 O
occlusion 140 149 777 786 O
or 150 152 787 789 O
encasement 153 163 790 800 O
of 164 166 801 803 O
the 167 170 804 807 O
superior 171 179 808 816 O
mesenteric 180 190 817 827 O
vein 191 195 828 832 O
or 196 198 833 835 O
superior 199 207 836 844 O
mesenteric 208 218 845 855 O
vein 219 223 856 860 O
/ 223 224 860 861 O
portal 224 230 861 867 O
vein 231 235 868 872 O
confluence 236 246 873 883 O
, 246 247 883 884 O
as 248 250 885 887 O
assessed 251 259 888 896 O
by 260 262 897 899 O
computed 263 271 900 908 B-treatment
tomography 272 282 909 919 I-treatment
( 283 284 920 921 I-treatment
CT 284 286 921 923 I-treatment
) 286 287 923 924 I-treatment
using 288 293 925 930 O
pancreatic 294 304 931 941 B-treatment
protocol 305 313 942 950 I-treatment
( 314 315 951 952 O
or 315 317 952 954 O
magnetic 318 326 955 963 B-treatment
resonance 327 336 964 973 I-treatment
imaging 337 344 974 981 I-treatment
[ 345 346 982 983 I-treatment
MRI 346 349 983 986 I-treatment
] 349 350 986 987 I-treatment
in 351 353 988 990 O
patients 354 362 991 999 O
who 363 366 1000 1003 O
can 367 370 1004 1007 O
not 370 373 1007 1010 O
undergo 374 381 1011 1018 O
CT 382 384 1019 1021 O
) 384 385 1021 1022 O
and 386 389 1023 1026 O
EUS 390 393 1027 1030 B-treatment

No 0 2 1031 1033 O
history 3 10 1034 1041 O
of 11 13 1042 1044 O
chronic 14 21 1045 1052 B-chronic_disease
diarrhea 22 30 1053 1061 I-chronic_disease

No 0 2 1062 1064 O
interstitial 3 15 1065 1077 B-chronic_disease
pneumonia 16 25 1078 1087 I-chronic_disease
or 26 28 1088 1090 O
extensive 29 38 1091 1100 O
and 39 42 1101 1104 O
symptomatic 43 54 1105 1116 O
interstitial 55 67 1117 1129 B-chronic_disease
fibrosis 68 76 1130 1138 I-chronic_disease
of 77 79 1139 1141 I-chronic_disease
the 80 83 1142 1145 I-chronic_disease
lung 84 88 1146 1150 I-chronic_disease

No 0 2 1151 1153 O
other 3 8 1154 1159 O
concurrent 9 19 1160 1170 O
anticancer 20 30 1171 1181 B-treatment
therapy 31 38 1182 1189 I-treatment

No 0 2 1190 1192 O
other 3 8 1193 1198 O
malignancy 9 19 1199 1209 B-cancer
within 20 26 1210 1216 O
past 27 31 1217 1221 B-upper_bound
five 32 36 1222 1226 I-upper_bound
years 37 42 1227 1232 I-upper_bound

No 0 2 1233 1235 O
prior 3 8 1236 1241 B-treatment
treatment 9 18 1242 1251 I-treatment
( 19 20 1252 1253 O
chemotherapy 20 32 1253 1265 B-treatment
, 32 33 1265 1266 O
biological 34 44 1267 1277 B-treatment
therapy 45 52 1278 1285 I-treatment
, 52 53 1285 1286 O
or 54 56 1287 1289 O
radiotherapy 57 69 1290 1302 B-treatment
) 69 70 1302 1303 O
for 71 74 1304 1307 O
resectable 75 85 1308 1318 O
pancreatic 86 96 1319 1329 B-cancer
cancer 97 103 1330 1336 I-cancer

No 0 2 1337 1339 O
prior 3 8 1340 1345 B-treatment
treatment 9 18 1346 1355 I-treatment
with 19 23 1356 1360 I-treatment
oxaliplatin 24 35 1361 1372 I-treatment
, 35 36 1372 1373 I-treatment
irinotecan 37 47 1374 1384 I-treatment
( 48 49 1385 1386 I-treatment
irinotecan 49 59 1386 1396 I-treatment
hydrochloride 60 73 1397 1410 I-treatment
) 73 74 1410 1411 I-treatment
, 74 75 1411 1412 I-treatment
fluorouracil 76 88 1413 1425 I-treatment
or 89 91 1426 1428 I-treatment
capecitabine 92 104 1429 1441 I-treatment

No 0 2 1442 1444 O
significant 3 14 1445 1456 O
cardiac 15 22 1457 1464 B-chronic_disease
disease 23 30 1465 1472 I-chronic_disease
, 30 31 1472 1473 O
including 32 41 1474 1483 O
the 42 45 1484 1487 O
following 46 55 1488 1497 O
: 55 56 1497 1498 O
unstable 57 65 1499 1507 B-chronic_disease
angina 66 72 1508 1514 I-chronic_disease
, 72 73 1514 1515 O
New 74 77 1516 1519 B-clinical_variable
York 78 82 1520 1524 I-clinical_variable
Heart 83 88 1525 1530 I-clinical_variable
Association 89 100 1531 1542 I-clinical_variable
class 101 106 1543 1548 I-clinical_variable
II 107 109 1549 1551 B-lower_bound
- 109 110 1551 1552 O
IV 110 112 1552 1554 B-upper_bound
congestive 113 123 1555 1565 B-chronic_disease
heart 124 129 1566 1571 I-chronic_disease
failure 130 137 1572 1579 I-chronic_disease
, 137 138 1579 1580 O
myocardial 139 149 1581 1591 B-chronic_disease
infarction 150 160 1592 1602 I-chronic_disease
within 161 167 1603 1609 O
six 168 171 1610 1613 B-treatment
months 172 178 1614 1620 I-treatment
prior 179 184 1621 1626 I-treatment
to 185 187 1627 1629 O
study 188 193 1630 1635 O
enrollment 194 204 1636 1646 O

No 0 2 1647 1649 O
uncontrolled 3 15 1650 1662 O
seizure 16 23 1663 1670 B-chronic_disease
disorder 24 32 1671 1679 I-chronic_disease
, 32 33 1679 1680 O
active 34 40 1681 1687 O
neurological 41 53 1688 1700 B-chronic_disease
disease 54 61 1701 1708 I-chronic_disease
, 61 62 1708 1709 O
or 63 65 1710 1712 O
known 66 71 1713 1718 O
central 72 79 1719 1726 B-chronic_disease
nervous 80 87 1727 1734 I-chronic_disease
system 88 94 1735 1741 I-chronic_disease
( 95 96 1742 1743 I-chronic_disease
CNS 96 99 1743 1746 I-chronic_disease
) 99 100 1746 1747 I-chronic_disease
disease 101 108 1748 1755 I-chronic_disease

Not 0 3 1756 1759 B-pregnancy
pregnant 4 12 1760 1768 I-pregnancy
and 13 16 1769 1772 O
not 17 20 1773 1776 O
nursing 21 28 1777 1784 O

Pathologic 0 10 1785 1795 O
or 11 13 1796 1798 O
cytologic 14 23 1799 1808 O
documentation 24 37 1809 1822 O
of 38 40 1823 1825 O
pancreatic 41 51 1826 1836 B-cancer
adenocarcinoma 52 66 1837 1851 I-cancer

Patients 0 8 1852 1860 O
who 9 12 1861 1864 O
received 13 21 1865 1873 O
chemotherapy 22 34 1874 1886 B-treatment
> 35 36 1887 1888 O
5 37 38 1889 1890 B-lower_bound
years 39 44 1891 1896 I-lower_bound
ago 45 48 1897 1900 I-lower_bound
for 49 52 1901 1904 O
malignancies 53 65 1905 1917 B-cancer
other 66 71 1918 1923 O
than 72 76 1924 1928 O
pancreatic 77 87 1929 1939 B-cancer
cancer 88 94 1940 1946 I-cancer
are 95 98 1947 1950 O
eligible 99 107 1951 1959 O

Platelet 0 8 1960 1968 B-clinical_variable
count 9 14 1969 1974 I-clinical_variable
> 15 16 1975 1976 O
= 16 17 1976 1977 O
100,000 18 25 1978 1985 B-lower_bound
/ 25 26 1985 1986 I-lower_bound
uL 26 28 1986 1988 I-lower_bound

Resectable 0 10 1989 1999 B-cancer
pancreatic 11 21 2000 2010 I-cancer
adenocarcinoma 22 36 2011 2025 I-cancer
disease 37 44 2026 2033 I-cancer

There 0 5 2034 2039 O
is 6 8 2040 2042 O
no 9 11 2043 2045 O
evidence 12 20 2046 2054 O
of 21 23 2055 2057 O
the 24 27 2058 2061 O
second 28 34 2062 2068 O
malignancy 35 45 2069 2079 B-cancer
at 46 48 2080 2082 O
the 49 52 2083 2086 O
time 53 57 2087 2091 O
of 58 60 2092 2094 O
study 61 66 2095 2100 O
entry 67 72 2101 2106 O

basal 0 5 2107 2112 B-cancer
cell 6 10 2113 2117 I-cancer
carcinoma 11 20 2118 2127 I-cancer
of 21 23 2128 2130 I-cancer
the 24 27 2131 2134 I-cancer
skin 28 32 2135 2139 I-cancer
, 32 33 2139 2140 O
cervical 34 42 2141 2149 B-cancer
carcinoma 43 52 2150 2159 I-cancer
in 53 55 2160 2162 I-cancer
situ 56 60 2163 2167 I-cancer
, 60 61 2167 2168 O
or 62 64 2169 2171 O
non 65 68 2172 2175 B-cancer
- 68 69 2175 2176 I-cancer
metastatic 69 79 2176 2186 I-cancer
prostate 80 88 2187 2195 I-cancer
cancer 89 95 2196 2202 I-cancer

